Asia-Pacific Blood Testing Market was worth $10 billion in 2018 and estimated to be growing at a CAGR of 3.35%, to reach $11.79 billion by 2023. During the forthcoming years, Asia-Pacific has been recognized as the fastest growing region.
Blood is a vital component of the body and is used routinely in a wide range of hospital procedures. Every year millions of units of blood are donated globally and used in necessary transplantation, cancer therapies, and accident victims and for patients undergoing other forms of surgeries.
Key factors contributing to the growth of this market contain growing number of chronic cases and high price of treatment, rise in occurrence of infectious diseases, speedily increasing aging population, boost in product approvals and launches, increase in demand for quick diagnostic techniques, and high commonness of bloodstream infections. Still, factor such as lack of technically skilled professionals is restraining the growth of this market.
The Asia-Pacific blood testing market is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase. Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Based on geography the Asia-Pacific market is analysed under various countries China, India, Japan, South Korea and Australia. China and India are the fastest growing market in the Asia-Pacific region.
Major players in this market are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Complete Blood Count
5.1.1.1 Red Blood Cells
5.1.1.2 White Blood Cells
5.1.1.3 Haemoglobin
5.1.1.4 Hematocrit
5.1.1.5 Platelets
5.1.2 Blood Chemistry Tests
5.1.2.1 Test for Electrolytes
5.1.2.2 Blood Glucose
5.1.2.3 Calcium
5.1.2.4 Test for Kidney Function
5.1.3 Blood Enzyme Tests
5.1.3.1 Troponin
5.1.3.2 Creatine Kinase
5.1.4 Blood Clotting Tests
5.1.4.1 Prothrombin time
5.1.4.2 Activated Partial Thromboplastin time
5.1.4.3 Blood Coagulation
5.2 By Diseases
5.2.1 Anaemia
5.2.2 Infection
5.2.3 Leukaemia
5.2.4 Hypokalemia
5.2.5 Kidney Disorders
5.2.6 Heart Attack
5.2.7 Coronary Heart Disease
5.3 By Methods
5.3.1 Manual Blood Culture Testing
5.3.2 Automated Blood Culture Testing
5.3.2.1 Automated Blood Culture System
5.3.2.2 Blood Culture Instruments
6. Geographical Analysis
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bio-Rad Laboratories Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Siemens Healthcare
8.3 Grifols
8.4 Nanosphere Inc.
8.5 BioMérieux
8.6 Dickinson and Company
8.7 Ortho Clinical Diagnostics Inc.
8.8 Roche Diagnostics
8.9 Alere Inc.
8.10 Bruker Corporation
8.11 Abbott Laboratories
8.12 Thermo Fisher Scientific Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
